The Ebers papyrus dating back to 1550 BC contains a treatise on the heart where it refers to this organ as the centre of the body's blood supply. 1 Although blood circulation was not described in this ancient document, diseases such as depression and dementia are discussed as well as their possible treatments. It is anybody's guess whether early Egyptian physicians suspected that the heart could have a role in mental disorders. Scrolling forward to 1977, an anonymous editor at The Lancet proposed that cardiac dysrhythmia and hypotension in the elderly could be an underdiagnosed cause of cognitive decline and dementia. 2 This provocative Editorial was promptly ignored by most readers and unceremoniously shot down by Emerson and colleagues 3 in 1981 when they reported no association between cardiac disease and dementia. Except for atrial fibrillation where only four patients from each group were studied, these authors did not examine dyscognitive patients with the cardiac abnormalities listed in Figure 1 , nor did they compare the demented patients with a cognitively intact control group. After the Emerson report, the issue of an important association between cardiovascular and cardiometabolic disease and dyscognitive function faded into limbo and it is only in the last 15 years that the subject has been revived, with dramatic findings.
It is now generally agreed by scientists in the field that the elderly brain, in particular, is a direct and indirect target organ of damage stemming from cardiovascular and cardiometabolic diseases. [4] [5] [6] That damage is often reflected by cognitive impairment which may come suddenly, as in ischaemic stroke, or in a protracted manner, as in chronic brain hypoperfusion. Cerebral hypoperfusion occurs when blood supply is not commensurate with neurometabolic demand. The precise reason why cardiovascular and cardiometabolic conditions are risk factors for dementia however, remains unknown.
Looking at Figure 1 , a number of cardiopathic conditions related to permanent cerebrovascular insufficiency have been shown in numerous studies to be risk factors for Alzheimer's disease (AD) and for vascular dementia (VaD), but the question still remains of why that is. Some possibilities have been considered including inflammation, oxidative stress, pro-thrombosis, and endothelial dysfunction. 7 Our own understanding of how cardiovascular disease increases the chance of cognitive impairment in the elderly points to a common factor that almost seamlessly connects the dots between cardiovascular defects and dyscognitive behaviour. That factor is chronic brain hypoperfusion. 8, 9 Three keystone pieces of evidence favour this conclusion:
i. several dozen risk factors for AD, including the cardiovascular conditions listed in Figure 1 , share a common vascular abnormality, i.e. lowering cerebral blood flow (CBF); 9 ii. a growing number of studies indicate that vascular risk factors including cardiometabolic disorders involving hypertension, type 2 diabetes, and coronary artery disease, as reported by Lyall and colleagues 10 in this issue, have been shown to be predictors of AD; 11 and
iii. interventions aimed at some of the conditions listed in Figure 1 appear to slow down cognitive decline.
12
Although the evidence linking cardiovascular and cardiometabolic diseases with cognitive impairment is tantalizing and promising, proof of concept requires a series of randomized controlled trials and long follow-up of patients.
In this regard, Lyall and his group 10 have taken an important step in that direction by examining visual memory, reaction time, and reasoning ability in an unprecedented cohort study composed of nearly half a million participants recruited from their UK Biobank database. They found statistically significant associations between hypertension, coronary artery disease, and type 2 diabetes with poor scores in the neurocognitive tests applied. Much poorer cognitive scores were seen when two or three of these cardiometabolic conditions were present in an individual, indicating an additive burden on cognitive function. 10 The effects of other cardiometabolic disorders on cognitive function such as the apoeE4 allele, stroke, obesity, and hyperlipidaemia were not examined in the present Biobank study. Although these researchers did not explore the possible reason(s) for their findings, it is tempting from their data to brainstorm the notion that chronic cerebral hypoperfusion during advanced ageing may have a direct, negative impact on cognitive behaviour. Consider the following. As we age, CBF typically diminishes at a rate of 0.5% per year, so from age 20 to 60, a 15-20% reduction in CBF is normally observed. 13 This gradual CBF decline generally does not cause any noticeable cognitive disturbance during advanced ageing. However, if one, or several vascular risk factors known to lower CBF 14 are acquired by the ageing individual, an additive effect to the ongoing age-related CBF decline will further dwindle brain cell energy supply to a point where cognitive impairment and AD are manifested. 15 Neurons need a constant supply of energy substrates to carry out their complicated motor, sensory, and cognitive tasks. Those energy substrates are derived strictly from blood pumped to the brain by the heart because the brain does not manufacture its own energy substrates. Cerebral autoregulation cannot reverse persistent and chronic cerebral hypoperfusion when cardiac output is compromised by specific cardiac pathology. 8 When structural or functional pathology impair the heart's ability to supply adequate blood flow to the brain, suboptimal delivery of energy substrates can, in time, disrupt the neural-metabolic demand and supply ratio, a process that will favour mild to catastrophic consequences on the cognitive status of the individual.
For these reasons, it is advisable that the relationship between poor brain blood flow and cognitive dysfunction during ageing should be vigorously pursued by basic and clinical research because it offers an auspicious and entirely feasible target of opportunity in preventing or reversing the development and fallout of cognitive meltdown in the elderly. Figure 1 Selected cardiovascular and cardiometabolic risk factors reported to impact the brain and induce cognitive dysfunction. These risk factors are all associated with cerebral hypoperfusion which in the aging individual may promote progressive cognitive decline and preclinical Alzheimer's disease. There is an overlap between atherosclerosis and coronary artery disease and between arteriosclerosis and aortic stiffening. The first two conditions are mainly due to an accumulation of white blood cells and cholesterol (fatty streaks) that can invade any artery, including coronary and carotid arteries. The last two conditions involve hardening and thickening of the arteries and aorta. These four conditions will reduce vessel elasticity and in time, restrict blood flow to one s organs including the brain.
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